CVE-2023-2980

CVE-2023-2980 is a medium-severity vulnerability in Abstrium Pydio Cells with a CVSS 3.x base score of 6.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-74.

Key facts

Description

A vulnerability classified as critical was found in Abstrium Pydio Cells 4.2.0. This vulnerability affects unknown code of the component User Creation Handler. The manipulation leads to improper control of resource identifiers. The attack can be initiated remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 4.2.1 is able to address this issue. It is recommended to upgrade the affected component. The identifier of this vulnerability is VDB-230212.

Frequently asked questions

What is CVE-2023-2980?
A vulnerability classified as critical was found in Abstrium Pydio Cells 4.2.0. This vulnerability affects unknown code of the component User Creation Handler. The manipulation leads to improper control of resource identifiers. The attack can be initiated remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 4.2.1 is able to address this issue. It is recommended to upgrade the affected component. The identifier of this vulnerability is VDB-230212.
How severe is CVE-2023-2980?
CVE-2023-2980 has a CVSS 3.x base score of 6.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability low.
Is CVE-2023-2980 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (62nd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-2980?
CVE-2023-2980 affects Abstrium Pydio Cells. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-2980?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2023-2980 published?
CVE-2023-2980 was published on 2023-05-30 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Abstrium Pydio Cells

All CVEs affecting Abstrium Pydio Cells →

Other CWE-74 (Improper Neutralization of Special Elements (Injection)) vulnerabilities

Browse all CWE-74 (Improper Neutralization of Special Elements (Injection)) vulnerabilities →